Microsoft’s New Responsible Tech Lead: What Changes, What Doesn’t
Microsoft has elevated a new leader for its Trusted Technology Group. Here’s what the move signals about “building it right” — and what remains uncertain.
Tag • 12 articles
AI & Big Tech
Articles currently tagged AI & Big Tech.
Inside the Rift Between Elon Musk and Sam Altman Over OpenAI
Once allies building OpenAI as a nonprofit, Elon Musk and Sam Altman now lead rival AI efforts. Their split reveals a power struggle over how AI should be built.
Why your AI chatbot isn’t a therapist — or a private diary
A courtroom dispute over Elon Musk and OpenAI is highlighting a basic risk: what you tell an AI chatbot may not stay between “you” and the machine.
Why Intellia’s Early 2026 Numbers Matter for Gene‑Editing Medicine
Intellia Therapeutics has reported its first‑quarter 2026 financials. Here’s what that disclosure signals about the state of CRISPR‑based drug development.
Musk–Altman court clash tests OpenAI’s original nonprofit mission
A California trial pits Elon Musk against Sam Altman over whether OpenAI abandoned its founding promise to develop AI for the public good.
SpaceX pours Starlink cash into AI push as Musk talks Mars
Starlink’s satellite internet profits are being funneled into AI at SpaceX, reshaping how the company funds Elon Musk’s Mars ambitions.
Alibaba Leads $290 Million Bet on Shengshu Vidu’s ‘World Model’ AI
Chinese tech giant backs Shengshu Vidu with a $290m round to develop a so‑called world model AI system aimed at richer real‑world simulations.
Why David Bianco Says the Pullback Is a Chance to Buy Big Tech
After weeks of weakness in major tech stocks, investment chief David Bianco argues the sell-off has gone too far and sees a buying opportunity.
What OpenAI’s latest funding remarks reveal about the AI race
A newly released OpenAI transcript shows how the lab is framing its latest funding phase, hinting at priorities in safety, scale and competition.
Microsoft’s AI Boom Collides With Its Climate Promises
Microsoft’s rapid AI expansion is driving up energy demand, putting its high-profile climate commitments under strain and forcing hard choices on power and policy.
Drug Giant Signs $2 Billion AI Deal, Marking Shift in Pharma Power
Eli Lilly has agreed to a $2 billion partnership to develop drugs using artificial intelligence, a move that could reshape how medicines are discovered.
AI’s Soaring Power Use Puts Tech Climate Pledges Under Strain
Major tech firms’ climate promises are colliding with the surging electricity demand of AI data centers, raising questions about how fast they can cut emissions.